×
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT

Landis admits to fraud

Last Updated : 25 August 2012, 16:04 IST
Last Updated : 25 August 2012, 16:04 IST

Follow Us :

Comments

Former professional cyclist Floyd Landis, who implicated team-mate Lance Armstrong in a doping scheme, agreed to a plea deal in federal court in San Diego on Friday, admitting he defrauded supporters out of nearly $500,000 by claiming that he himself had not doped, prosecutors said.

Landis was in court on the same day Armstrong was stripped of his seven Tour de France titles and banned from professional cycling after dropping his challenge to US Anti-Doping Agency charges against him. Prosecutors said the timing was coincidental and that the case against Landis, who won the Tour de France in 2006 but was disqualified for doping, had been in the works for months.

As part of the plea agreement, Landis, who has acknowledged using performance-enhancing drugs during his career, agreed to repay $478,354 in funds he raised for the ‘Floyd Fairness Fund’ while battling the USADA.

He did not plead guilty but acknowledged wrongdoing under a ‘deferred prosecution agreement’ that calls for prosecutors to dismiss wire fraud charges against him in three years if he lives up to his end of the deal.

"We didn't make him plead guilty but we made him admit the facts that are necessary to get a guilty plea," Assistant US Attorney Phil Halpern said.

An attorney for the former athlete could not be reached for comment following the hearing.

Prosecutors said that after he tested positive for exogenous testosterone during the 2006 Tour de France, Landis raised money from 1,765 contributors through town hall meetings, online videos, charity rides, a book and personal appeals -- based in large part on his denials that he had doped.

Landis accused Armstrong in 2010 of using performance-enhancing drugs and teaching others how to avoid being caught.

ADVERTISEMENT
Published 25 August 2012, 16:04 IST

Deccan Herald is on WhatsApp Channels| Join now for Breaking News & Editor's Picks

Follow us on :

Follow Us

ADVERTISEMENT
ADVERTISEMENT